Prof Jim Gallagher - Trustee




Professor Jim Gallagher holds the Derby Chair of Anatomy and Cell Biology at the University of Liverpool. Jim obtained his PhD from Cambridge on the metabolism of vitamin D under Eric Lawson. He undertook postdoctoral research in Herbie Fleisch's lab in Bern on bisphosphonates, then Graham Russell's lab in Sheffield where with Jon Beresford, he developed the first techniques to culture osteoblastic cells from human bone.


 In 1984 he was appointed to a lectureship at University College London (UCL) where he worked with Alan Boyde. He moved to Liverpool in 1986 and has undertaken short sabbaticals in Melbourne with Jack Martin working on PTHrP, and at Ciba-Geigy, Basle with Graeme Bilbe on gene expression in bone. Jim has published over 150 full peer-reviewed publications, 20 book chapters and five patents. He has supervised 35 PhD students, 10 of whom hold academic positions in UK universities. 

For the past decade, his research has focussed on investigating the mechanism of joint destruction in the inherited disease alkaptonuria (AKU), in collaboration with L Ranganath. Jim has been the main organiser of the International Workshops on AKU and has spoken at several AKU patient workshop




AKU Twitter

AKU Blog

Rare Disease Day 2019
14-Mar-2019

Rare Disease Day is an international day designed to raise awareness to the public and those.. ...more

Cambridge Half Marathon 2019: On the Day
08-Mar-2019

Last Sunday our two runners, Ana and Katja, both completed the Cambridge Half Marathon. They rai.. ...more

Cambridge Half Marathon 2019: Meet the Runners
22-Feb-2019

The Cambridge Half Marathon is Next Sunday. On the 3rd March our two runners will tackle the roa.. ...more

Final meeting of DevelopAKUre and the 11th Scientific workshop on AKU – Siena 2019
15-Feb-2019

The AKU Society has just come back from a hectic week in the beautiful Italian city of Siena.. ...more

SONIA 2 - Last patients
22-Jan-2019

On the 18th January, the last SONIA 2 (Suitability of Nitisinone In Alkaptonuria 2) patients.. ...more